Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400079956Phase 4Not yet recruiting
Phase 4, randomised trial of ropivacaine in gastric cancer (GC) and colorectal cancer (CRC) (3 arms), sponsored by Taixing People's Hospital. Primary endpoint: QoR-15 score after surgery. Planned start Jan 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400079956.